The main signaling pathways determining the microglia responses in spinal cord injury: Potential effectors among

E R Akhmetzyanova1, A A Rizvanov2, Y O Mukhamedshina3

  • 1OpenLab Gene and Cell Technology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Experimental Neurology
|October 24, 2025
PubMed

Insights

Spinal cord injury triggers complex cell reactions, particularly in microglia. Understanding microglial signaling pathways could lead to new treatments for spinal cord injury and prevent disability.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Spinal cord injury (SCI) involves complex, multi-component posttraumatic reactions affecting all central nervous system cells.
  • Microglia are primary responders to nervous tissue damage, exhibiting activation states that drive either pro-inflammatory or anti-inflammatory responses.
  • Current therapeutic strategies for SCI have not yet succeeded in preventing disability.

Purpose of the Study:

  • To identify key effectors within microglial cell signaling pathways that influence their behavior following spinal cord injury.
  • To explore the potential for repurposing existing drugs by understanding these signaling pathways for future clinical applications in SCI treatment.

Main Methods:

  • Literature review focusing on microglial cell activation and signaling pathways in the context of spinal cord injury.
  • Analysis of existing knowledge on cell activation signaling pathways and drug development.

Main Results:

  • Microglia play a crucial role in the inflammatory response post-SCI, with their activation status determining the outcome.
  • Specific signaling pathways in microglia are critical in mediating their pro- or anti-inflammatory actions.
  • Understanding these pathways offers potential therapeutic targets.

Conclusions:

  • Identifying microglial signaling pathway effectors is a promising avenue for developing effective SCI treatments.
  • Repurposing existing drugs targeting these pathways could offer novel therapeutic strategies for SCI patients.
  • This research holds potential for future clinical applications in managing spinal cord injuries.